These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 435366)

  • 1. Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
    Kaye SB; Juttner CA; Smith IE; Barrett A; Austin DE; Peckham MJ; McElwain TJ
    Br J Cancer; 1979 Feb; 39(2):168-74. PubMed ID: 435366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
    Dady PJ; McElwain TJ; Austin DE; Barrett A; Peckham MJ
    Br J Cancer; 1982 Jun; 45(6):851-9. PubMed ID: 7093120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
    McElwain TJ; Toy J; Smith E; Peckham MJ; Austin DE
    Br J Cancer; 1977 Aug; 36(2):276-80. PubMed ID: 911666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of Hodgkin's disease.
    Malpas JS
    J R Coll Physicians Lond; 1980 Jan; 14(1):26-33. PubMed ID: 6160241
    [No Abstract]   [Full Text] [Related]  

  • 5. CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
    Vose JM; Bierman PJ; Anderson JR; Weisenburger D; Moravec DF; Sorensen S; Hutchins M; Dowling MD; Howe D; Okerbloom J
    J Clin Oncol; 1991 Aug; 9(8):1421-5. PubMed ID: 2072145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
    Cullen MH; Stuart NS; Woodroffe C; Murphy A; Fletcher J; Blackledge GR; Child JA; Grieve RJ; Jones EL
    J Clin Oncol; 1994 Apr; 12(4):779-87. PubMed ID: 7512132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChlVPP chemotherapy in advanced Hodgkin's disease.
    McKendrick JJ; Mead GM; Sweetenham J; Jones DH; Williams CJ; Ryall R; Whitehouse JM
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):557-61. PubMed ID: 2703008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment maintaining complete remission in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
    [No Abstract]   [Full Text] [Related]  

  • 9. The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's disease.
    Norum J; Bremnes RM; Wist E
    Eur J Haematol; 1994 Jul; 53(1):51-3. PubMed ID: 8062898
    [No Abstract]   [Full Text] [Related]  

  • 10. ChlVPP: reducing toxicity in the treatment of Hodgkin's disease.
    Mansi JL
    Eur J Cancer; 1992; 28A(8-9):1411-3. PubMed ID: 1515260
    [No Abstract]   [Full Text] [Related]  

  • 11. ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
    Selby P; Patel P; Milan S; Meldrum M; Mansi J; Mbidde E; Brada M; Perren T; Forgeson G; Gore M
    Br J Cancer; 1990 Aug; 62(2):279-85. PubMed ID: 2386744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
    Timothy AR; Sutcliffe SB; Wrigley PF; Jones AE
    Int J Radiat Oncol Biol Phys; 1979 Feb; 5(2):165-9. PubMed ID: 457468
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy in stages I or II Hodgkin's disease.
    Lauria F; Baccarani M; Fiaccini M; Mazza P; Tura S
    Lancet; 1979 Nov; 2(8151):1072-3. PubMed ID: 91806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)].
    Komarnicki M; Balcerzak A; Górski P; Pawlak L; Hansz J
    Acta Haematol Pol; 1994; 25(4):363-8. PubMed ID: 7531381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
    Stout R; Todd ID
    Cancer Treat Rev; 1979 Jun; 6 Suppl():107-13. PubMed ID: 498163
    [No Abstract]   [Full Text] [Related]  

  • 16. ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
    Radford JA; Rohatiner AZ; Ryder WD; Deakin DP; Barbui T; Lucie NP; Rossi A; Dunlop DJ; Cowan RA; Wilkinson PM; Gupta RK; James RD; Shamash J; Chang J; Crowther D; Lister TA
    J Clin Oncol; 2002 Jul; 20(13):2988-94. PubMed ID: 12089229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MVPP chemotherapy regimen for advanced Hodgkin's disease.
    Sutcliffe SB; Wrigley PF; Peto J; Lister TA; Stansfeld AG; Whitehouse JM; Crowther D; Malpas JS
    Br Med J; 1978 Mar; 1(6114):679-83. PubMed ID: 630293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
    Ekert H; Waters KD; Smith PJ; Toogood I; Mauger D
    J Clin Oncol; 1988 Dec; 6(12):1845-50. PubMed ID: 3058876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients.
    Saletti P; Zucca E; Gueneau M; Peccatori F; Cavalli F; Martinelli G
    Leuk Lymphoma; 1999 Apr; 33(3-4):313-9. PubMed ID: 10221511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
    Aiba K; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Dohmyo M; Nagata T; Miyamoto H; Kobayashi T; Kuraishi Y
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1928-32. PubMed ID: 6897857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.